Bayesian Capital Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,480
| Closed | -$84.1K | – | 995 |
|
|
2022
Q4 | $84.1K | Buy |
2,480
+460
| +23% | +$15.6K | 0.01% | 677 |
|
|
2022
Q3 | $97K | Sell |
2,020
-3,460
| -63% | -$166K | 0.02% | 599 |
|
|
2022
Q2 | $312K | Buy |
+5,480
| New | +$312K | 0.06% | 468 |
|
|
2021
Q2 | – | Sell |
-918
| Closed | -$275K | – | 568 |
|
|
2021
Q1 | $275K | Sell |
918
-257
| -22% | -$77K | 0.06% | 368 |
|
|
2020
Q4 | $300K | Buy |
+1,175
| New | +$300K | 0.08% | 305 |
|
|
2018
Q3 | – | Sell |
-867
| Closed | -$635K | – | 746 |
|
|
2018
Q2 | $635K | Buy |
867
+369
| +74% | +$270K | 0.14% | 210 |
|
|
2018
Q1 | $793K | Sell |
498
-529
| -52% | -$842K | 0.2% | 164 |
|
|
2017
Q4 | $920K | Buy |
+1,027
| New | +$920K | 0.19% | 184 |
|
|
2017
Q2 | – | Sell |
-745
| Closed | -$262K | – | 544 |
|
|
2017
Q1 | $262K | Sell |
745
-868
| -54% | -$305K | 0.12% | 283 |
|
|
2016
Q4 | $297K | Buy |
+1,613
| New | +$297K | 0.07% | 430 |
|